EC-Logo-2018_TM_CMYK.jpg
electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
December 17, 2024 16:05 ET | electroCore, Inc.
The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to discuss acquisition and host investor Q&A in a webcast today at...
EC-Logo-2018_TM_CMYK.jpg
electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis
November 19, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has donated 20 gammaCore...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21
November 14, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Third Quarter 2024 Financial Results
November 13, 2024 16:01 ET | electroCore, Inc.
Record quarterly revenues driven by 75% YoY growth of Rx gammaCore™ in the VA/DoD and 147% increase in Truvaga™ sales  Company to host a conference call and webcast today, November 13, 2024 at...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024
October 23, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in Upcoming Investor Conferences
September 26, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
EC-Logo-2018_TM_CMYK.jpg
electroCore Engages FNK IR to Execute Expanded Investor Relations Program
September 24, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Second Quarter 2024 Financial Results
August 07, 2024 16:01 ET | electroCore, Inc.
Seventh consecutive record quarterly net sales of $6.1 million, an increase of 73% over second quarter 2023  Company to host a conference call and webcast today, August 7, 2024 at 4:30 PM EST ...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024
July 31, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...